Equities

Alterola Biotech Inc

ABTI:PKC

Alterola Biotech Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.0037
  • Today's Change0.00 / 0.00%
  • Shares traded3.05k
  • 1 Year change-89.12%
  • Beta-3.8593
Data delayed at least 15 minutes, as of Apr 22 2024 14:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Alterola Biotech, Inc. is a pharmaceutical company. The Company is engaged in the development of cannabinoid, cannabinoid-like, and non-cannabinoid pharmaceutical active pharmaceutical ingredients (APIs); pharmaceutical medicines made from cannabinoid, cannabinoid-like, and non-cannabinoid APIs; and European food approval of cannabinoid-based, cannabinoid-like, and non-cannabinoid ingredients and products. The Company has three areas of focus: development of regulated pharmaceuticals (human and animal health) and regulated food products; production of APIs and food-grade ingredients; and formulation, and drug delivery, providing bioavailability, solubility, and stability. It also focuses on developing new medicines from various sources, including botanical, traditional chemical synthesis, and biosynthetic methodologies. Its wholly owned subsidiaries include ABTI Pharma Ltd, Phytotherapeutix Ltd, and Ferven Ltd.

  • Revenue in USD (TTM)0.00
  • Net income in USD-2.88m
  • Incorporated2008
  • Employees1.00
  • Location
    Alterola Biotech Inc47 Hamilton SquarBIRKENHEAD CH415ARUnited KingdomGBR
  • Phone+1 909 584 5853
  • Websitehttps://alterola-abti.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Oragenics Inc37.65k-20.66m4.71m5.00--2.05--124.97-8.69-8.690.01671.030.0038----7,530.00-209.44-97.60-252.98-106.24-----54,862.55-36,169.75----0.0898---71.37---44.56--51.64--
Shineco Inc4.50m-13.99m4.94m87.00--0.0127--1.10-3.93-4.630.443160.930.05580.39320.984451,761.38-18.99-12.77-34.44-16.8411.9425.88-340.48-102.060.4903-9.040.3792-----58.35-33.86------
Genprex Inc0.00-30.86m4.95m26.00--0.4728-----22.93-22.930.004.990.00----0.00-172.62-92.06-207.88-98.32------------0.00-------29.99---7.13--
Alzamend Neuro Inc0.00-15.16m5.05m4.00---------2.32-2.320.00-0.41460.00----0.00-265.85---496.81-------------1,736.10---------20.35------
Alterola Biotech Inc0.00-2.88m5.05m1.00---------0.0027-0.00270.00-0.0010.00----0.00-47.24---63.88----------0.0019----------73.07------
Lipella Pharmaceuticals Inc449.62k-4.62m5.06m5.00--1.44--11.26-0.7858-0.78580.07490.51940.0944--6.1689,924.00-96.96---116.00-------1,027.31------0.00--144.15---77.81------
Portage Biotech Inc0.00-144.90m5.14m7.00--0.1606-----7.96-7.960.001.620.00----0.00-111.60-19.70-113.27-26.48------------0.0087-------520.10------
Synaptogenix Inc0.00-13.78m5.17m5.00--0.1884-----43.56-43.560.0026.550.00----0.00-17.32-40.33-18.83-43.36------------0.00-------142.17---3.21--
Helix BioMedix, Inc.2.07m-2.58m5.23m8.00--3.35--2.53-15.60-15.6012.486.950.80471.874.55258,238.80-100.64-146.31-120.73-173.5768.9630.80-125.06-527.121.69-14.570.00--122.0792.8067.73---29.08--
HST Global Inc0.00-146.22k5.25m1.00---------0.0279-0.02790.00-0.11280.00-------17,002.33-5,836.01---------------26.54---------0.7858------
Silo Pharma Inc72.12k-3.63m5.26m3.00--0.8704--72.94-1.18-1.210.02342.130.0074--2.1924,040.00-37.46-24.90-39.95-26.3991.9082.79-5,034.79-2,757.85----0.00--0.00--7.07------
Halberd Corp281.24k25.34k5.34m3.003.62--210.5418.990.00230.00230.0018-0.00020.14490.03032.52--1.31--4.58--50.00--9.01--0.26611.351.02--271.52---60.11------
NLS Pharmaceutics AG0.00-15.47m5.38m2.00---------0.534-0.5340.00-0.13220.00----0.00-714.74-308.05---------------175.42---------38.08------
Fresh Tracks Therapeutics Inc8.01m-5.69m5.44m4.00--0.5474--0.679-1.38-1.381.491.660.7326----2,001,500.00-52.10-89.76-66.50-115.24-----71.12-442.61---1,272.000.00--15.3137.6273.02------
Data as of Apr 22 2024. Currency figures normalised to Alterola Biotech Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.